Franklin G. Berger - Publications

Affiliations: 
1986- University of South Carolina, Columbia, SC 
Area:
Molecular Biology, Genetics

138 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Berger FG, Boland CR. Preface. Advances in Cancer Research. 151: xv-xvi. PMID 34148622 DOI: 10.1016/S0065-230X(21)00058-0  0.164
2020 Zahnd WE, Gomez SL, Steck SE, Brown MJ, Ganai S, Zhang J, Arp Adams S, Berger FG, Eberth JM. Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer. Cancer. PMID 33112412 DOI: 10.1002/cncr.33256  0.263
2020 Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ, Berger FG. Publisher Correction: Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology. PMID 32601393 DOI: 10.1038/S41575-020-0338-0  0.362
2020 Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ, Berger FG. Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology. PMID 32086499 DOI: 10.1038/S41575-019-0253-4  0.374
2019 Singh N, Berger FG. Evolution of a mammalian promoter through changes in patterns of transcription factor binding Journal of Molecular Evolution. 48: 252. PMID 9929395 DOI: 10.1007/Pl00006463  0.344
2019 Love B, Chiodini S, Hofseth L, Bolick S, Berger F. PCN152 AGE-ADJUSTED COLORECTAL CANCER INCIDENCE IN THE UNITIED STATES VERSUS SOUTH CAROLINA Value in Health. 22: S84. DOI: 10.1016/J.JVAL.2019.04.276  0.26
2019 Love B, Chiodini S, Hofseth L, Bolick S, Berger F. PCN149 COMPARISON OF EARLY AND LATE-ONSET COLORECTAL CANCER AMONG SOUTH CAROLINA RESIDENTS Value in Health. 22: S84. DOI: 10.1016/J.JVAL.2019.04.273  0.27
2018 Zhou B, Zhang X, Wang G, Barbour KW, Berger FG, Wang Q. Drug screening assay based on the interaction of intact Keap1 and Nrf2 proteins in cancer cells. Bioorganic & Medicinal Chemistry. PMID 30473361 DOI: 10.1016/J.Bmc.2018.11.019  0.401
2018 Zhang Q, Berger FG, Love B, Banister CE, Murphy EA, Hofseth LJ. Maternal stress and early-onset colorectal cancer. Medical Hypotheses. 121: 152-159. PMID 30396471 DOI: 10.1016/J.Mehy.2018.09.035  0.383
2018 Luque JS, Wallace K, Blankenship BF, Roos LG, Berger FG, LaPelle NR, Melvin CL. Correction to: Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think. Journal of Community Health. PMID 29882181 DOI: 10.1007/s10900-018-0534-9  0.206
2018 Luque JS, Wallace K, Blankenship BF, Roos LG, Berger FG, LaPelle NR, Melvin CL. Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think. Journal of Community Health. PMID 29767821 DOI: 10.1007/S10900-018-0525-X  0.35
2018 Kaur K, Saxena A, Debnath I, O'Brien JL, Ajami NJ, Auchtung TA, Petrosino JF, Sougiannis AJ, Depaep S, Chumanevich A, Gummadidala PM, Omebeyinje MH, Banerjee S, Chatzistamou I, Chakraborty P, ... ... Berger FG, et al. Antibiotic-mediated bacteriome depletion in Apcmice is associated with reduction in mucus-producing goblet cells and increased colorectal cancer progression. Cancer Medicine. PMID 29624892 DOI: 10.1002/Cam4.1460  0.399
2018 Jülicher K, Wähner A, Haase K, Barbour KW, Berger FG, Wiehlmann L, Davenport C, Schuster-Gossler K, Stitz J, Cantz T, Eggenschwiler R. Functional characterization of the mouse Serpina1 paralog DOM-7. Biological Chemistry. PMID 29498931 DOI: 10.1515/Hsz-2018-0154  0.383
2018 Eberth JM, Thibault A, Caldwell R, Josey MJ, Qiang B, Peña E, LaFrance D, Berger FG. A statewide program providing colorectal cancer screening to the uninsured of South Carolina. Cancer. PMID 29415338 DOI: 10.1002/Cncr.31250  0.37
2018 Sharman SK, Islam BN, Hou Y, Singh N, Berger FG, Sridhar S, Yoo W, Browning DD. Cyclic-GMP elevating agents suppress polyposis in Apc min mice by targeting the preneoplastic epithelium. Cancer Prevention Research (Philadelphia, Pa.). PMID 29301746 DOI: 10.1158/1940-6207.Capr-17-0267  0.45
2017 Peterse EFP, Meester RGS, Gini A, Doubeni CA, Anderson DS, Berger FG, Zauber AG, Lansdorp-Vogelaar I. Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries. Health Affairs (Project Hope). 36: 2151-2159. PMID 29200350 DOI: 10.1377/Hlthaff.2017.0228  0.364
2017 Chandrashekaran V, Seth RK, Dattaroy D, Alhasson F, Ziolenka J, Carson J, Berger FG, Kalyanaraman B, Diehl AM, Chatterjee S. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. Redox Biology. 13: 8-19. PMID 28551086 DOI: 10.1016/J.Redox.2017.05.005  0.394
2017 Islam BN, Sharman SK, Hou Y, Bridges AE, Singh N, Kim S, Kolhe R, Trillo-Tinoco J, Rodriguez PC, Berger FG, Sridhar S, Browning DD. Sildenafil suppresses Inflammation-driven Colorectal Cancer in mice. Cancer Prevention Research (Philadelphia, Pa.). PMID 28468928 DOI: 10.1158/1940-6207.Capr-17-0015  0.442
2017 Clinton SA, Barbour KW, Berger FG. Abstract B16: Activation of NRF2 and adaptive resistance to chemotherapy Cancer Research. 77. DOI: 10.1158/1538-7445.Crc16-B16  0.321
2017 Peterse EF, Meester R, Gini A, Berger FG, Zauber AG, Lansdorp-Vogelaar I. Cost-Effectiveness of Waiving all Copayments for Colorectal Cancer Screening Among Medicare Beneficiaries Gastroenterology. 152: S174-S175. DOI: 10.1016/S0016-5085(17)30900-9  0.359
2016 Chandrashekaran V, Dattaroy D, Das S, Alhasson F, Seth R, Carson J, Berger F, Zielnoka J, Kalyanaraman B, Chatterjee S. The Receptor for Advanced Glycation End Product (RAGE) Binding to HMGB1 and Subsequent NADPH Oxidase Activation Mediates Ectopic Intestinal Inflammation in NAFLD Free Radical Biology and Medicine. 100: S37. DOI: 10.1016/J.Freeradbiomed.2016.10.095  0.399
2015 Ozer U, Barbour KW, Clinton SA, Berger FG. Oxidative Stress and Response to Thymidylate Synthase-Targeted Antimetabolites. Molecular Pharmacology. 88: 970-81. PMID 26443810 DOI: 10.1124/Mol.115.099614  0.746
2015 Wallace K, Brandt HM, Bearden JD, Blankenship BF, Caldwell R, Dunn J, Hegedus P, Hoffman BJ, Marsh CH, Marsh WH, Melvin CL, Seabrook ME, Sterba RE, Stinson ML, Thibault A, ... Berger FG, et al. Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina. Digestive Diseases and Sciences. PMID 26386856 DOI: 10.1007/S10620-015-3862-Y  0.356
2015 van der Steen A, Knudsen AB, van Hees F, Walter GP, Berger FG, Daguise VG, Kuntz KM, Zauber AG, van Ballegooijen M, Lansdorp-Vogelaar I. Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina. Health Services Research. 50: 768-89. PMID 25324198 DOI: 10.1111/1475-6773.12246  0.369
2015 Berger FG, Hansen CW. The Medicare loophole: cost-sharing for screening colonoscopy Colorectal Cancer. 4: 221-223. DOI: 10.2217/Crc.15.26  0.381
2015 Wallace K, Alberg A, Blankenship B, Brandt H, Caldwell R, Dunn J, Hegedus P, Hoffman B, Marsh C, Seabrook M, Stinson M, Thibault A, Berger F. Abstract B85: Racial differences in the risk of serrated polyps and conventional adenomas in a younger aged, uninsured population in South Carolina Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B85  0.354
2014 Berger FG. Patient navigation and cancer disparities in the era of personalized medicine Colorectal Cancer. 3: 109-112. DOI: 10.2217/Crc.14.9  0.351
2014 Ozer U, Berger FG, Barbour KW. Abstract 5504: A potential source in oxidative cell death mediated by thymidylate synthase inhibitors: NADPH oxidase 2 Cancer Research. 74: 5504-5504. DOI: 10.1158/1538-7445.Am2014-5504  0.455
2014 Clinton SA, Barbour KW, Ozer U, Berger FG. Abstract 493: NRF2 modulates sensitivity to thymidylate synthase inhibitors in colon cancer cells Cancer Research. 74: 493-493. DOI: 10.1158/1538-7445.Am2014-493  0.448
2014 van der Steen A, Knudsen AB, Van Hees F, Walter G, Berger FG, Daguise V, Kuntz KM, Zauber AG, Van Ballegooijen M, Lansdorp-Vogelaar I. 957 Optimal Colorectal Cancer Screening Strategy for States' Low-Income, Uninsured Populations -The Case of South Carolina Gastroenterology. 146: S-169. DOI: 10.1016/S0016-5085(14)60599-0  0.362
2013 Huntoon KM, Russell L, Tracy E, Barbour KW, Li Q, Shrikant PA, Berger FG, Garrett-Sinha LA, Baumann H. A unique form of haptoglobin produced by murine hematopoietic cells supports B-cell survival, differentiation and immune response. Molecular Immunology. 55: 345-54. PMID 23548836 DOI: 10.1016/J.Molimm.2013.03.008  0.396
2013 Wallace K, Hill EG, Lewin DN, Williamson G, Oppenheimer S, Ford ME, Wargovich MJ, Berger FG, Bolick SW, Thomas MB, Alberg AJ. Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes & Control : Ccc. 24: 463-71. PMID 23296454 DOI: 10.1007/S10552-012-0133-5  0.366
2013 Barbour KW, Xing YY, Peña EA, Berger FG. Characterization of the bipartite degron that regulates ubiquitin-independent degradation of thymidylate synthase. Bioscience Reports. 33: 165-73. PMID 23181752 DOI: 10.1042/Bsr20120112  0.376
2013 Lo PK, Lee JS, Chen H, Reisman D, Berger FG, Sukumar S. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas. Experimental and Molecular Pathology. 94: 262-9. PMID 23103611 DOI: 10.1016/J.Yexmp.2012.10.014  0.421
2013 Berger FG. Interview: Screening and treatment for colorectal cancer Colorectal Cancer. 2: 117-120. DOI: 10.2217/Crc.13.12  0.369
2013 Heriot A, Guillén-Ponce C, Carrato A, Berger FG. Journal Watch: Our experts highlight the most important research articles across the spectrum of topics relevant to the field of colorectal cancer Colorectal Cancer. 2: 109-111. DOI: 10.2217/Crc.13.11  0.396
2013 Ozer U, Barbour KW, Berger FG. Abstract 2112: The role of reactive oxygen species (ROS) in cell death induced by thymidylate synthase inhibitors. Cancer Research. 73: 2112-2112. DOI: 10.1158/1538-7445.Am2013-2112  0.44
2012 Brandt HM, Dolinger HR, Sharpe PA, Hardin JW, Berger FG. Relationship of colorectal cancer awareness and knowledge with colorectal cancer screening. Colorectal Cancer. 1: 383-396. PMID 26257828 DOI: 10.2217/Crc.12.45  0.363
2012 McClellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, Carson JA, Pena MM, Carnevale KA, Berger FG, Murphy EA. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. American Journal of Physiology. Gastrointestinal and Liver Physiology. 303: G1087-95. PMID 23019193 DOI: 10.1152/Ajpgi.00252.2012  0.41
2012 Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, Chen H. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFΒ signaling Oncogene. 31: 2614-2626. PMID 21996747 DOI: 10.1038/Onc.2011.439  0.393
2012 Eng C, Berger FG, López-Cerón M, Castells A, Minsky BD. Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of colorectal cancer Colorectal Cancer. 1: 15-16. DOI: 10.2217/Crc.11.11  0.354
2011 Melo SP, Barbour KW, Berger FG. Cooperation between an intrinsically disordered region and a helical segment is required for ubiquitin-independent degradation by the proteasome. The Journal of Biological Chemistry. 286: 36559-67. PMID 21878626 DOI: 10.1074/Jbc.M111.274258  0.405
2011 Zhang X, Berger FG, Yang J, Lu X. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. The Embo Journal. 30: 2177-89. PMID 21522127 DOI: 10.1038/Emboj.2011.125  0.41
2011 Davis C, Price R, Acharya G, Baudino T, Borg T, Berger FG, Peña MM. Hematopoietic derived cell infiltration of the intestinal tumor microenvironment in Apc Min/+ mice. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 17: 528-39. PMID 21473808 DOI: 10.1017/S1431927611000043  0.389
2011 Zhang X, Wan G, Berger FG, He X, Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Molecular Cell. 41: 371-83. PMID 21329876 DOI: 10.1016/J.Molcel.2011.01.020  0.323
2010 Melo SP, Yoshida A, Berger FG. Functional dissection of the N-terminal degron of human thymidylate synthase. The Biochemical Journal. 432: 217-26. PMID 20815815 DOI: 10.1042/Bj20101027  0.385
2010 Zhang X, Wan G, Mlotshwa S, Vance V, Berger FG, Chen H, Lu X. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Research. 70: 7176-86. PMID 20668064 DOI: 10.1158/0008-5472.Can-10-0697  0.376
2010 Baltgalvis KA, Berger FG, Peña MM, Mark Davis J, White JP, Carson JA. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 109: 1155-61. PMID 20651218 DOI: 10.1152/Japplphysiol.00442.2010  0.384
2010 Huang X, Gibson LM, Bell BJ, Lovelace LL, Peña MM, Berger FG, Berger SH, Lebioda L. Replacement of Val3 in human thymidylate synthase affects its kinetic properties and intracellular stability . Biochemistry. 49: 2475-82. PMID 20151707 DOI: 10.1021/Bi901457E  0.599
2009 Peña MM, Melo SP, Xing YY, White K, Barbour KW, Berger FG. The intrinsically disordered N-terminal domain of thymidylate synthase targets the enzyme to the ubiquitin-independent proteasomal degradation pathway. The Journal of Biological Chemistry. 284: 31597-607. PMID 19797058 DOI: 10.1074/Jbc.M109.038455  0.406
2009 Baltgalvis KA, Berger FG, Peña MM, Davis JM, Carson JA. The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice. Cancer Prevention Research (Philadelphia, Pa.). 2: 641-9. PMID 19549797 DOI: 10.1158/1940-6207.Capr-09-0017  0.352
2009 Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M, Fogelman AM, Reddy ST. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. The Journal of Biological Chemistry. 284: 18292-301. PMID 19433579 DOI: 10.1074/Jbc.M109.017202  0.374
2009 Yang X, Wood PA, Ansell CM, Ohmori M, Oh EY, Xiong Y, Berger FG, Peña MM, Hrushesky WJ. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. Journal of Biochemistry. 145: 289-97. PMID 19106159 DOI: 10.1093/Jb/Mvn167  0.398
2009 Baltgalvis KA, Berger FG, Peña MM, Davis JM, White JP, Carson JA. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. Pflã¼Gers Archiv : European Journal of Physiology. 457: 989-1001. PMID 18712412 DOI: 10.1007/S00424-008-0574-6  0.376
2008 Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Peña MM, Hrushesky WJ. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Molecular Cancer Research : McR. 6: 1786-93. PMID 19010825 DOI: 10.1158/1541-7786.Mcr-08-0196  0.432
2008 Ghatak S, Hascall V, Berger F, Penas MMO, Davis C, Jabari E, He X, Norris J, Dang Y, Markwald RR, Misra S. Tissue-Specific shRNA delivery: A novel approach for gene therapy in cancer Connective Tissue Research. 49: 265-269. PMID 18661357 DOI: 10.1080/03008200802147845  0.372
2008 Misra S, Hascall VC, Berger FG, Markwald RR, Ghatak S. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer Connective Tissue Research. 49: 219-224. PMID 18661347 DOI: 10.1080/03008200802143356  0.391
2008 Thangaraju M, Cresci G, Itagaki S, Mellinger J, Browning DD, Berger FG, Prasad PD, Ganapathy V. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 12: 1773-81; discussion . PMID 18661192 DOI: 10.1007/S11605-008-0573-0  0.352
2008 Huntoon KM, Wang Y, Eppolito CA, Barbour KW, Berger FG, Shrikant PA, Baumann H. The acute phase protein haptoglobin regulates host immunity. Journal of Leukocyte Biology. 84: 170-81. PMID 18436583 DOI: 10.1189/Jlb.0208100  0.384
2008 Misra S, Obeid LM, Hannun YA, Minamisawa S, Berger FG, Markwald RR, Toole BP, Ghatak S. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells Journal of Biological Chemistry. 283: 14335-14344. PMID 18326857 DOI: 10.1074/Jbc.M703811200  0.406
2008 Kwon IK, Schoenlein PV, Delk J, Liu K, Thangaraju M, Dulin NO, Ganapathy V, Berger FG, Browning DD. Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis. Cancer. 112: 1462-70. PMID 18260092 DOI: 10.1002/Cncr.23334  0.408
2008 Baltgalvis KA, Berger FG, Peña MM, Davis JM, Carson JA. Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps. Journal of Applied Physiology (Bethesda, Md. : 1985). 104: 1137-43. PMID 18239078 DOI: 10.1152/Japplphysiol.00955.2007  0.361
2008 Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ, Carson JA. Interleukin-6 and cachexia in ApcMin/+ mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 294: R393-401. PMID 18056981 DOI: 10.1152/Ajpregu.00716.2007  0.375
2008 Barbour KW, Berger FG. Cell death in response to antimetabolites directed at thymidylate synthase. Cancer Chemotherapy and Pharmacology. 61: 189-201. PMID 17396263 DOI: 10.1007/S00280-007-0461-4  0.395
2008 Carmichael MD, Davis M, Murphy A, Carson J, Berger FG. Brain Inflammation in the ApcMin/+ Mouse Model of Colon Cancer Medicine & Science in Sports & Exercise. 40: S16. DOI: 10.1249/01.Mss.0000321514.26903.11  0.374
2007 Berger FG, Kramer DL, Porter CW. Polyamine metabolism and tumorigenesis in the Apc(Min/+) mouse. Biochemical Society Transactions. 35: 336-9. PMID 17371273 DOI: 10.1042/Bst0350336  0.416
2007 Blum S, Asaf R, Guetta J, Miller-Lotan R, Asleh R, Kremer R, Levy NS, Berger FG, Aronson D, Fu X, Zhang R, Hazen SL, Levy AP. Haptoglobin genotype determines myocardial infarct size in diabetic mice. Journal of the American College of Cardiology. 49: 82-7. PMID 17207726 DOI: 10.1016/J.Jacc.2006.08.044  0.321
2007 Baltgalvis KA, Berger FG, Davis JM, Carson JA. Skeletal Muscle Apoptosis During Cancer Cachexia in the Apc−/+ Mouse Medicine & Science in Sports & Exercise. 39: S221. DOI: 10.1249/01.Mss.0000273836.43623.Af  0.363
2006 Berger FG, Berger SH. Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years? Cancer Biology & Therapy. 5: 1238-41. PMID 17035726 DOI: 10.4161/Cbt.5.9.3414  0.318
2006 You S, Ohmori M, Peña MM, Nassri B, Quiton J, Al-Assad ZA, Liu L, Wood PA, Berger SH, Liu Z, Wyatt MD, Price RL, Berger FG, Hrushesky WJ. Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. International Journal of Experimental Pathology. 87: 227-36. PMID 16709231 DOI: 10.1111/J.1365-2613.2006.00477.X  0.404
2006 Peña MM, Xing YY, Koli S, Berger FG. Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase. The Biochemical Journal. 394: 355-63. PMID 16259621 DOI: 10.1042/Bj20051479  0.427
2006 Baltgalvis KA, Washington TA, Davis JM, Berger FG, Carson JA. Muscle Wasting and the Role of IL-6 in Cachectic ApcMin/+ Mice Medicine & Science in Sports & Exercise. 38: S282. DOI: 10.1249/00005768-200605001-02095  0.345
2006 Price RL, Pena MMO, Davis C, Ogawa M, Borg TK, Berger FG. Hematopoietic stem cells in the APCMin/+ mouse model of colon cancer: Migration, differentiation and genetic modification Microscopy and Microanalysis. 12: 10-11. DOI: 10.1017/S1431927606063331  0.372
2005 Mehl KA, Davis JM, Berger FG, Carson JA. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse. Journal of Applied Physiology (Bethesda, Md. : 1985). 99: 2379-87. PMID 16288100 DOI: 10.1152/Japplphysiol.00778.2005  0.382
2005 Tucker JM, Murphy JT, Kisiel N, Diegelman P, Barbour KW, Davis C, Medda M, Alhonen L, Jänne J, Kramer DL, Porter CW, Berger FG. Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1- acetyltransferase Cancer Research. 65: 5390-5398. PMID 15958588 DOI: 10.1158/0008-5472.Can-05-0229  0.441
2005 Mehl KA, Davis JM, Clements JM, Berger FG, Pena MM, Carson JA. Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 98: 2219-25. PMID 15894538 DOI: 10.1152/Japplphysiol.00975.2004  0.357
2005 Miller-Lotan R, Herskowitz Y, Kalet-Litman S, Nakhoul F, Aronson D, Zoabi R, Asaf R, Ben-Izhak O, Sabo E, Lim SK, Baumann H, Berger FG, Levy AP. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diabetes/Metabolism Research and Reviews. 21: 332-7. PMID 15852445 DOI: 10.1002/Dmrr.556  0.338
2005 Mchl KA, McClung JM, Davis JM, Berger FG, Carson JA. Skeletal Muscle Atrophy Is Associated With Chronic Inflammation In The APCMin+/- Mouse Medicine & Science in Sports & Exercise. 37: S32???S33. DOI: 10.1097/00005768-200505001-00184  0.328
2004 Berger FG. The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality. Breast Cancer Research and Treatment. 88: 281-5. PMID 15609131 DOI: 10.1007/S10549-004-0726-0  0.383
2004 Murphy JT, Tucker JM, Davis C, Berger FG. Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ mice. Cancer Biology & Therapy. 3: 1169-76. PMID 15539941 DOI: 10.4161/Cbt.3.11.1220  0.403
2004 Forsthoefel AM, Peña MM, Xing YY, Rafique Z, Berger FG. Structural determinants for the intracellular degradation of human thymidylate synthase. Biochemistry. 43: 1972-9. PMID 14967037 DOI: 10.1021/Bi035894P  0.406
2004 Berger SH, Berger FG, Lebioda L. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase. Biochimica Et Biophysica Acta. 1696: 15-22. PMID 14726200 DOI: 10.1016/J.Bbapap.2003.09.005  0.605
2004 Porter C, Kee K, Kramer D, Berger F. 93 Genetic validation of activated polyamine catabolism as a novel therapeutic strategy targeting prostate cancer European Journal of Cancer Supplements. 2: 31. DOI: 10.1016/S1359-6349(04)80101-0  0.25
2004 Berger F, Davis C, Tucker J, Kramer D, Porter C. 68 Spermine/spermidine N1-acetyltransferase: a new target for prevention and/or therapy of colorectal cancer European Journal of Cancer Supplements. 2: 24. DOI: 10.1016/S1359-6349(04)80076-4  0.267
2003 Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine & Growth Factor Reviews. 14: 25-34. PMID 12485617 DOI: 10.1016/S1359-6101(02)00054-0  0.38
2003 Yang F, Haile DJ, Berger FG, Herbert DC, Van Beveren E, Ghio AJ. Haptoglobin reduces lung injury associated with exposure to blood American Journal of Physiology - Lung Cellular and Molecular Physiology. 284. PMID 12388365 DOI: 10.1152/Ajplung.00115.2002  0.38
2003 Tucker JM, Davis C, Kitchens ME, Bunni MA, Priest DG, Spencer H, Berger FG. Erratum to “Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc/+ mice” [Cancer Lett. 187 (2002) 153–162] Cancer Letters. 202: 119. DOI: 10.1016/J.Canlet.2003.08.018  0.371
2002 Barbour KW, Wei F, Brannan C, Flotte TR, Baumann H, Berger FG. The murine alpha(1)-proteinase inhibitor gene family: polymorphism, chromosomal location, and structure. Genomics. 80: 515-22. PMID 12408969 DOI: 10.1016/S0888-7543(02)96864-3  0.312
2002 Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, Silengo L, Altruda F. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood. 100: 4201-8. PMID 12393471 DOI: 10.1182/Blood-2002-04-1270  0.402
2002 Tucker JM, Davis C, Kitchens ME, Bunni MA, Priest DG, Spencer HT, Berger FG. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice. Cancer Letters. 187: 153-62. PMID 12359363 DOI: 10.1016/S0304-3835(02)00402-0  0.391
2002 Hochepied T, Wullaert A, Berger FG, Baumann H, Brouckaert P, Steidler L, Libert C. Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. Gut. 51: 398-404. PMID 12171963 DOI: 10.1136/gut.51.3.398  0.281
2002 Barbour KW, Goodwin RL, Guillonneau F, Wang Y, Baumann H, Berger FG. Functional diversification during evolution of the murine alpha(1)-proteinase inhibitor family: role of the hypervariable reactive center loop. Molecular Biology and Evolution. 19: 718-27. PMID 11961105 DOI: 10.1093/Oxfordjournals.Molbev.A004130  0.711
2002 Wang Y, Kinzie E, Berger FG, Lim SK, Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Report : Communications in Free Radical Research. 6: 379-85. PMID 11865981 DOI: 10.1179/135100001101536580  0.408
2002 Barbour KW, Wei F, Brannan C, Flotte TR, Baumann H, Berger FG. The Murine α1-Proteinase Inhibitor Gene Family: Polymorphism, Chromosomal Location, and Structure Genomics. 80: 515-522. DOI: 10.1006/Geno.2002.6864  0.409
2001 Barbour KW, Davis T, White A, Baumann H, Berger FG. Haptoglobin, inflammation, and tumorigenesis in the MIN mouse. Redox Report : Communications in Free Radical Research. 6: 366-8. PMID 11865977 DOI: 10.1179/135100001101536553  0.393
2001 Barker C, Barbour KW, Berger FG, Hajduk SL. Activity of human trypanosome lytic factor in mice. Molecular and Biochemical Parasitology. 117: 129-36. PMID 11606222 DOI: 10.1016/S0166-6851(01)00339-5  0.378
2001 Shaw D, Berger FG, Spencer HT. Retroviral expression of Escherichia coli thymidylate synthase cDNA confers high-level antifolate resistance to hematopoietic cells. Human Gene Therapy. 12: 51-9. PMID 11177542 DOI: 10.1089/104303401450960  0.396
2000 Hochepied T, Van Molle W, Berger FG, Baumann H, Libert C. Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. The Journal of Biological Chemistry. 275: 14903-9. PMID 10809735 DOI: 10.1074/Jbc.275.20.14903  0.38
2000 Fantz C, Shaw D, Jennings W, Forsthoefel A, Kitchens M, Phan J, Minor W, Lebioda L, Berger FG, Spencer HT. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254. Molecular Pharmacology. 57: 359-66. PMID 10648646 DOI: 10.2210/Pdb1Qqq/Pdb  0.599
1999 Kitchens ME, Forsthoefel AM, Barbour KW, Spencer HT, Berger FG. Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability. Molecular Pharmacology. 56: 1063-70. PMID 10531414 DOI: 10.1124/Mol.56.5.1063  0.421
1999 Persson K, Heby O, Berger FG. The functional intronless S-adenosylmethionine decarboxylase gene of the mouse (Amd-2) is linked to the ornithine decarboxylase gene (Odc) on chromosome 12 and is present in distantly related species of the genus Mus. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 10: 784-8. PMID 10430664 DOI: 10.1007/S003359901092  0.397
1999 Libert C, Hochepied T, Berger FG, Baumann H, Fiers W, Brouckaert P. High-level constitutive expression of alpha 1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice. Transgenic Research. 7: 429-35. PMID 10341451 DOI: 10.1023/A:1008810429645  0.416
1999 Kitchens ME, Forsthoefel AM, Rafique Z, Spencer HT, Berger FG. Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation. The Journal of Biological Chemistry. 274: 12544-7. PMID 10212232 DOI: 10.1074/JBC.274.18.12544  0.318
1998 Singh N, Berger FG. Evolution of a mammalian promoter through changes in patterns of transcription factor binding. Journal of Molecular Evolution. 46: 639-48. PMID 9608046 DOI: 10.1007/Pl00006344  0.351
1998 Singh N, Barbour KW, Berger FG. Evolution of transcriptional regulatory elements within the promoter of a mammalian gene. Molecular Biology and Evolution. 15: 312-25. PMID 9501498 DOI: 10.1093/Oxfordjournals.Molbev.A025928  0.376
1997 Reilly RT, Forsthoefel AM, Berger FG. Functional effects of amino acid substitutions at residue 33 of human thymidylate synthase. Archives of Biochemistry and Biophysics. 342: 338-43. PMID 9186496 DOI: 10.1006/abbi.1997.0116  0.315
1997 Goodwin RL, Barbour KW, Berger FG. Expression of the alpha 1-proteinase inhibitor gene family during evolution of the genus Mus. Molecular Biology and Evolution. 14: 420-7. PMID 9100372 DOI: 10.1093/Oxfordjournals.Molbev.A025778  0.715
1996 Goodwin RL, Baumann H, Berger FG. Patterns of divergence during evolution of α 1-proteinase inhibitors in mammals Molecular Biology and Evolution. 13: 346-358. PMID 8587500 DOI: 10.1093/Oxfordjournals.Molbev.A025594  0.715
1996 Betzner TM, Doty JR, Hamad AMA, Henderson HT, Berger FG. Structural design and characteristics of a thermally isolated, sensitivity-enhanced, bulk-micromachined, silicon flow sensor Journal of Micromechanics and Microengineering. 6: 217-227. DOI: 10.1088/0960-1317/6/2/003  0.187
1994 Asadi FK, Dimaculangan DD, Berger FG. Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. Endocrinology. 134: 1179-87. PMID 8119157 DOI: 10.1210/endo.134.3.8119157  0.301
1993 Johannes GJ, Berger FG. Domains within the mammalian ornithine decarboxylase messenger RNA have evolved independently and episodically Journal of Molecular Evolution. 36: 555-567. PMID 8350350 DOI: 10.1007/Bf00556360  0.375
1993 Hughey CT, Barbour KW, Berger FG, Berger SH. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine. Advances in Experimental Medicine and Biology. 339: 67-76. PMID 8178730 DOI: 10.1007/978-1-4615-2488-5_8  0.414
1993 Kass DH, Berger FG, Dawson WD. The evolution of coexisting highly divergent LINE-1 subfamilies within the rodent genus Peromyscus. Journal of Molecular Evolution. 35: 472-85. PMID 1474601 DOI: 10.1007/Bf00160208  0.333
1991 Rhee M, Dimaculangan D, Berger FG. Androgen modulation of DNA-binding factors in the mouse kidney. Molecular Endocrinology (Baltimore, Md.). 5: 564-72. PMID 1922089 DOI: 10.1210/Mend-5-4-564  0.382
1991 Mackiewicz A, Dewey MJ, Berger FG, Baumann H. Acute phase mediated change in glycosylation of rat alpha 1-acid glycoprotein in transgenic mice. Glycobiology. 1: 265-9. PMID 1794039 DOI: 10.1093/Glycob/1.3.265  0.294
1991 Chaudhuri A, Barbour KW, Berger FG. Evolution of messenger RNA structure and regulation in the genus Mus: the androgen-inducible RP2 mRNAs. Molecular Biology and Evolution. 8: 641-53. PMID 1766361 DOI: 10.1093/oxfordjournals.molbev.a040675  0.298
1990 Berger FG. Assignment of a gene encoding ornithine decarboxylase to the proximal region of chromosome 12 in the mouse. Biochemical Genetics. 27: 745-53. PMID 2627199 DOI: 10.1007/Bf02396065  0.38
1990 Latimer JJ, Berger FG, Baumann H. Highly conserved upstream regions of the alpha 1-antitrypsin gene in two mouse species govern liver-specific expression by different mechanisms. Molecular and Cellular Biology. 10: 760-9. PMID 1689000 DOI: 10.1128/Mcb.10.2.760  0.407
1990 Girard Madoux M, Martin X, Bachet P, Coppere B, Vialard F, Rague S, Michaud E, Berger F, Ninet J, Pasquier J. Dissections primitives a priori isolées de l'artère rénale La Revue De MéDecine Interne. 11: S53. DOI: 10.1016/S0248-8663(05)81958-7  0.175
1989 Rheaume C, Schonfeld C, Porter C, Berger FG. Evolution of androgen-regulated ornithine decarboxylase expression in mouse kidney. Molecular Endocrinology (Baltimore, Md.). 3: 1243-51. PMID 2779581 DOI: 10.1210/Mend-3-8-1243  0.404
1989 Rheaume C, Barbour KW, Tseng-Crank J, Berger FG. Molecular genetics of androgen-inducible RP2 gene transcription in the mouse kidney. Molecular and Cellular Biology. 9: 477-83. PMID 2710112 DOI: 10.1128/Mcb.9.2.477  0.41
1989 Berger FG, Watson G. Androgen-regulated gene expression. Annual Review of Physiology. 51: 51-65. PMID 2653194 DOI: 10.1146/annurev.ph.51.030189.000411  0.297
1989 Nadeau JH, Berger FG, Cox DR, Crosby JL, Davisson MT, Ferrara D, Fuchs E, Hari C, Hunihan L, Lalley PA, Langley SH, Martin GR, Nichols L, Phillips SJ, Roderick TH, et al. A family of type I keratin genes and the homeobox-2 gene complex are closely linked to the rex locus on mouse chromosome 11 Genomics. 5: 454-462. PMID 2482246 DOI: 10.1016/0888-7543(89)90009-8  0.366
1988 Tseng-Crank J, Schonfeld C, Berger FG. Evolution of androgen-regulated mRNA expression in mouse kidney. Molecular Biology and Evolution. 5: 442-54. PMID 3405078 DOI: 10.1093/Oxfordjournals.Molbev.A040506  0.404
1988 Barbour KW, Berger SH, Berger FG, Thompson EA. Glucocorticoid regulation of the genes encoding thymidine kinase, thymidylate synthase, and ornithine decarboxylase in P1798 cells. Molecular Endocrinology (Baltimore, Md.). 2: 78-84. PMID 3398844 DOI: 10.1210/mend-2-1-78  0.314
1988 Berger SH, Davis ST, Barbour KW, Berger FG. The role of thymidylate synthase in the response to fluoropyrimidine-folinic acid combinations. Advances in Experimental Medicine and Biology. 244: 59-69. PMID 2977716 DOI: 10.1007/978-1-4684-5607-3_6  0.388
1988 Conte JM, Souquet JC, Valette PJ, Berger F, Moulinier B. Gastric linitis and breast cancer: an association not to be disregarded | Linite gastrique et cancer du sein: une association à ne pas méconnaître Acta Endoscopica. 18: 119-125. DOI: 10.1007/BF02962994  0.251
1987 Porter CW, Berger FG, Pegg AE, Ganis B, Bergeron RJ. Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine Biochemical Journal. 242: 433-440. PMID 3036091 DOI: 10.1042/Bj2420433  0.324
1986 Berger FG, Loose D, Meisner H, Watson G. Androgen induction of messenger RNA concentrations in mouse kidney is posttranscriptional. Biochemistry. 25: 1170-5. PMID 3964664 DOI: 10.1021/Bi00353A034  0.377
1986 Baumann H, Berger FG. Genetics and evolution of the acute phase proteins in mice. Molecular & General Genetics : Mgg. 201: 505-12. PMID 3866909 DOI: 10.1007/Bf00331347  0.417
1986 Berger FG, Porter CW. Putrescine does not mediate the androgen-response in mouse kidney Biochemical and Biophysical Research Communications. 138: 771-777. PMID 3091023 DOI: 10.1016/S0006-291X(86)80563-0  0.411
1985 Buset M, Baize M, Dez Marez B, Bourgeois N, De Boelpaepe C, De Toeuf J, Cremer M, Cusumano A, Norberto L, Martella B, Buin F, Aneona E, Lambert R, Spinelli P, Dal Fants M, ... ... Berger F, et al. VIe Symposium International d’Endoscopie Digestive Acta Endoscopica. 15: 63-116. DOI: 10.1007/BF02966115  0.189
1983 Berger FG. Studies on genetic variation in major urinary protein synthesis in mouse liver. Biochemical Genetics. 21: 15-23. PMID 6838486 DOI: 10.1007/Bf02395388  0.376
1983 Elliott RW, Berger FG. DNA sequence polymorphism in an androgen-regulated gene is associated with alteration in the encoded RNAs. Proceedings of the National Academy of Sciences of the United States of America. 80: 501-4. PMID 6188152 DOI: 10.1073/pnas.80.2.501  0.264
1982 Berger FG, Szoka P. Biosynthesis of the major urinary proteins in mouse liver: a biochemical genetic study. Biochemical Genetics. 19: 1261-73. PMID 7337697 DOI: 10.1007/Bf00484578  0.388
1980 Berger FG, Paigen K. Cis-active control of mouse beta-galactosidase biosynthesis by a systemic regulatory locus. Nature. 282: 314-6. PMID 116134 DOI: 10.1038/282314a0  0.284
1978 Berger FG, Lusis AJ. Relationship between genetic variation in thermal stability and electrophoretic mobility of mouse β-galactosidase Biochemical Genetics. 16: 1007-1014. PMID 105715 DOI: 10.1007/Bf00483750  0.368
1975 Berger FG, Herrmann KM. Tryptophan synthetase α(5.7-S): novel molecular species formed within Escherichia coli Journal of Bacteriology. 124: 800-809. PMID 1102532  0.72
Show low-probability matches.